FORWARD FEATURES CALENDAR

Allocations

Kenect, a provider of business texting and communications technology, has secured a strategic growth investment from funds advised by PSG, a growth equity firm partnering with middle-market software and technology-enabled service companies.  The investment aims to fuel Kenect’s next phase of growth including: Continued product innovation, scaling the go-to-market, adding to the customer support organisation and pursuing strategic acquisitions, all in order to better serve Kenect’s growing list of clients across North America. Financial terms have not been disclosed. “We couldn’t be more excited to work with PSG to continue our mission of connecting businesses with consumers through our messaging
TCG Crossover (TCG X), in partnership with The Column Group, has raised an inaugural USD824 million fund focused on crossover and public investments in the life sciences.  The oversubscribed fund attracted an array of premier investors including university endowments, family offices, pension funds and sovereign wealth funds. TCG X invests exclusively in innovative drug discovery companies that are seeking to make an impact on unmet medical needs. By leveraging its relationship with The Column Group and its Science Partners, the firm adds extensive scientific and operating expertise to its portfolio companies. While TCG X will invest in some late stage
Neal Costello AlpInvest
In a yet a further sign of continuing maturity in private equity, its secondary market is being driven by GP-led deals, giving rise to a greater proliferation of single asset transactions. And as AlpInvest’s Neal Costello explains, this is presenting wider opportunities for liquidity providers.  
Forbion, a European life sciences venture capital firm, has held the final close of the Forbion Growth Opportunities Fund I (Forbion Growth I) at its hard cap amount of EUR360 million (USD428 million).  Forbion Growth I is focused on investing in late-stage European life sciences companies. Pantheon, Eli Lilly and Company, Horizon Therapeutics, the Belgian Growth Fund, New Waves Investments, Wealth Management Partners, KfW Capital and the European Investment Fund (EIF) are part of a strong base of institutional LPs that supported the fund. Forbion Growth I concentrates on later-stage investments, particularly in European biotech companies that develop novel therapies
Feel, the UK-based digital health company, has closed a GBP4.5 million investment, led by Fuel Ventures and including TMT Investments, Sova VC, Richard Longhurst (founder of LoveHoney.com) and Igor Ryabenkiy (founder and GP of Altair Capital).   Feel is on a mission to clean up the ‘dirty’ world of nutritional supplements and is producing high-quality supplements following an exceptional first year of growth. Increasingly health-conscious consumers spend GBP442million a year on nutritional supplements, oblivious to falling foul of poor quality, ineffective nutrients.  The global dietary supplements market has become a high growth sector in recent years. In 2019, the market
Sunaina Sinha, Cebile Capital
In this week’s podcast, Sunaina Sinha, managing partner at Cebile Capital, discusses the findings of the firm’s recent survey of 100 global LPs, including how LPs have shifted their modus operandi in 2020, who the winners are in terms of allocation flow during the pandemic, and the fact that 51 per cent of LPs expect to increase commitments to private equity in 2021.
musicMagpie, a re-commerce business in the UK and US specialising in refurbished consumer technology, has secured GBP20 million in growth financing through a GBP10 million committed revolving credit facility and a GBP10 million accordion facility from Silicon Valley Bank (SVB) UK Branch.  
Bite Investments, a fintech company with an alternative investment platform, has closed on its Pre Series A+ funding in a round led by JMP Group (JMP), an investment banking and alternative asset management firm headquartered in San Francisco, California. “We are continuing to attract progressive partners who recognise the steady growth and related opportunities associated with both our robust fintech platform and the soaring global private equity market,” says Bite CEO William Rudebeck. “It is a testimony to how the financial industry and investor community are gravitating toward alternative investment opportunities, as well as digitalisation and its transformative value.”  
Financial Services Capital, a private equity investor dedicated to the European financial services sector, has completed USD15 million in new financing for NYMBUS, a provider of banking technology solutions, doubling its total investment in the company to more than USD31 million. As part of the investment, Matt Wallach, Co-Founder of Veeva Systems, will join as a Strategic Advisor and Matthew Hansen, Managing Partner at Financial Services Capital, will join Managing Partner Miroslav Boublik on the Nymbus Board of Directors. Financial Services Capital launched in 2020 to capitalise on a once-in-a-generation investment opportunity, transforming businesses through a hands-on, operationally focused and
Keensight Capital, a private equity managers dedicated to pan-European Growth buyout investments, has acquired a majority stake in RAM Infotechnology (RAM-IT), a leading managed services company dedicated to the Healthcare sector based in the Netherlands.  Keensight Capital will leverage its extensive experience in Tech and Healthcare to support RAM-IT’s founders and management team in their ambitious development goals. Founded 20 years ago, RAM-IT is the leading player in managed services for the Healthcare sector in the Netherlands and a technology leader in Europe, with 220 employees expert in IT infrastructure management. Growing steadily for many years, RAM-IT’s revenues have increased

Events

12 November, 2026 – 8:00 am

Directory Listings